The sale is modest relative to market cap and the insider's likely total holdings. Monitor for actual Form 4 filings to confirm execution; no immediate read-through for the stock.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 9 $259.67entry
- T+1 · 7d ago −0.47%α −0.11% · $258.44
- T+5 · 15h ago +0.98%α +2.67% · $262.21
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Patrick Plewman, an officer of Quest Diagnostics, filed a Form 144 notice to sell 11,717 shares of common stock with an approximate market value of $3.0M. The shares were acquired through restricted stock vesting and a stock option exercise. This is an advance notice of intent to sell, not a completed transaction.
Key Facts
- Reporting owner: Patrick Plewman (Officer)
- Shares to be sold: 11,717 shares of common stock
- Approximate value: $3,015,252.78
- Shares acquired via restricted stock vesting (650 shares on 02/24/2025) and stock option exercise (11,067 shares on 11/09/2026)
- Broker: Fidelity Brokerage Services LLC
- Proposed sale date: 11/09/2026
- Exchange: NYSE
Financial Impact
Proposed sale of $3.0M worth of common stock, representing a small fraction of the $28.0B market cap (0.01%).
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur
- Insider selling could be perceived negatively if it precedes a negative catalyst, though no such catalyst is indicated in the filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007844 |
| Document: 0001959173-26-007844-index.html | 0001959173-26-007844 |
| Document: 0001959173-26-007844.txt | 0001959173-26-007844 |
Track record
24 reports on DGX
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +7.06% at T+5 after the Sep 9, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $262.21 +1.01% settles Feb 11
- Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $262.21 +1.36% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $262.21 +1.46% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
- Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $259.67 Now $262.21 +0.98% settles Feb 5
- Nov 5, 202611d ago 3 Neutral 2/10 Entry $255.63 Now $262.21 +2.57% settles Feb 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
- Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $262.21 +6.75% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers